Derivatives of sobetirome
US-10870616-B2 · Dec 22, 2020 · US
US2021300853A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2021300853-A1 |
| Application number | US-202117212605-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 25, 2021 |
| Priority date | Mar 30, 2020 |
| Publication date | Sep 30, 2021 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject invention pertains to a method of halogenating phenols, yielding a range of halogenated phenols with enantiomeric ratio of up to 99.5:0.5. In certain embodiments, the subject invention pertains to a method of asymmetric halogenation of bisphenol, yielding a range of chiral bisphenol ligands. The novel chiral bisphenols are potent privileged catalyst cores that can be applied to the preparation of ligands for various catalytic asymmetric reactions. The catalyst library can easily be accessed because late-stage modification of the scaffold can readily be executed through cross-coupling of the halogen handles on the bisphenols.
Opening claim text (preview).
We claim: 1 . A method of halogenation, the method comprising contacting a reactant bisphenol with a source of a halogen in the presence of a catalyst under process conditions sufficient to prepare a halogenated bisphenol. 2 . The method of claim 1 , wherein the bisphenol is a mono-halogenated bisphenol and has alkyl, aryl, and/or electron-withdrawing substituents. 3 . The method of claim 1 , wherein the halogen source is a source of chlorine or a source of bromine. 4 . The method of claim 3 , wherein the chlorine source is DCDPH and the bromine source is NBS. 5 . The method of claim 1 , wherein the halogen source is provided in a concentration of about 0.01 mmol to about 1 mmol or in a stoichiometrically equivalent amount relative to the bisphenol reactant; and the catalyst is provided at a concentration of about 0.1 mol % to about 10 mol %. 6 . The method of claim 1 , wherein the catalyst is an amino organocatalyst selected from N-[3,5-bis(trifluoromethyl)phenyl]-N′-[(1S,2S)-2-(dimethylamino)cyclohexyl]urea; N-[3,5-bis(trifluoromethyl)phenyl]-N′-[(1S,2S)-2-(di-n-pentylamino)cyclohexyl]urea; 3-[[3,5-bis(trifluoromethyl)phenyl]amino]-4-[R1S,2S)-2-(dimethylamino)cyclohexyl]amino]-3-cyclobutene-1,2-dione; N-[3,5-bis(trifluoromethyl)phenyl]-N′-[(1S,2S)-2-[(11bS)-3,5-dihydro-4H-dinaphth[2,1-c:1′,2′-e]azepin-4-yl]cyclohexyl]urea; or N-[3,5-bis(trifluoromethyl)phenyl]-N′-[(1S,2S)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1′,2′-e]azepin-4-yl]cyclohexyl]urea. 7 . The method of claim 1 , wherein the process conditions comprise the presence of a solvent; and, the process occurs at a temperature of about −80° C. to about 80° C., about −78° C. to about 0° C., or about −78° C. to about −40° C. for about 2 hours to about 7 days, about 1 day to about 5 days, or about 4 days to about 5 days. 8 . The method of claim 7 , wherein the solvent is an aromatic hydrocarbon, a carbon tetrachloride, or a combination thereof; and the ratio of aromatic hydrocarbon to carbon tetrachloride in the solvent is 2:1, 3:1, 4:1, or 5:1. 9 . The method of claim 8 , wherein the aromatic hydrocarbon is toluene. 10 . The method of claim 7 , wherein the process conditions further comprise the addition of a molecular sieve with a pore size of about 0.1 Å to about 100 Å, about 1 Å to about 10 Å, or about 4 Å. 11 . The method of claim 1 , further comprising cross-coupling the halogenated bisphenol to prepare a substituted bisphenol, wherein the halogen of the halogenated bisphenol is substituted with an acid. 12 . The method of claim 11 , wherein the halogenated bisphenol is a bihalogenated bisphenol. 13 . The method of claim 12 , wherein the bihalogenated bisphenol comprises two different halogens. 14 . The method of claim 11 , wherein the acid is 1-naphthyl boronic acid and/or 2-naphthyl boronic acid. 15 . The method of claim 11 , further comprising preparing a dihydroxyl catalyst from the acid-substituted bisphenol. 16 . The method of claim 15 , wherein the dihydroxyl catalyst is a chiral phosphoric acid catalyst. 17 . The method of claim 15 , further comprising using the dihydroxyl catalyst to catalyze an asymmetric catalytic reaction. 18 . The method claim 17 , wherein the asymmetric catalytic reaction is an addition of an indole to an imine to prepare an adduct corresponding to the indole and the imine addition or a preparation of 3,4-dihydropyrimin-2(1H)-one using aldehyde, urea, and ethyl acetoacetate. 19 . The method of claim 1 , further comprising preparing a chiral phosphoramidite ligand from the halogenated bisphenol. 20 . A chiral bisphenol prepared according to the method of claim 1 , wherein the chiral bisphenol is an asymmetric ortho-halogenated bisphenol. 21 . A chiral organocatalyst scaffold prepared according to the method of claim 15 . 22 . A chiral phosphoramidite ligand prepared according to the method of claim 19 .
Ketones or ketals · CPC title
Halogen-containing compounds · CPC title
Copper · CPC title
1,4-additions, e.g. conjugate additions · CPC title
Enamines · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.